Union Bancaire Privee’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Buy
19,021
+3,861
+25% +$509K 0.02% 250
2026
Q1
$1.72M Buy
15,160
+1,031
+7% +$144K 0.02% 250
2025
Q4
$1.42M Buy
14,129
+6,810
+93% +$828K 0.02% 260
2025
Q3
$621K Sell
7,319
-1,782
-20% -$203K 0.01% 293
2025
Q2
$745K Sell
9,101
-7,711
-46% -$821K 0.01% 283
2025
Q1
$1.46M Buy
16,812
+80
+0.5% +$8.26K 0.03% 206
2024
Q4
$1.24M Buy
+16,732
New +$1.51M 0.02% 256

Other funds holding GILD

Union Bancaire Privee's GILD Position: Q2 2026 in Review

Union Bancaire Privee increased its Gilead Sciences (GILD) stake by 25% in Q2 2026, buying an estimated $509K and bringing the position to 19,021 shares worth $1.98M. The position accounts for 0.02% of the portfolio, ranked #250.

Union Bancaire Privee first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Union Bancaire Privee held 19,021 shares of Gilead Sciences worth $1.98M as of Q2 2026.
  • Union Bancaire Privee bought 3,861 Gilead Sciences shares in Q2 2026, an estimated $509K.
  • Gilead Sciences made up 0.02% of Union Bancaire Privee's portfolio in Q2 2026, its #250 holding.
  • Union Bancaire Privee first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.